Back
Comstock Resources Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
43
CRK
Comstock Resources
Last Price:
15.57
Seasonality Move:
-2.61%
Sell
49
SRPT
Sarepta Therapeutics
Last Price:
130.47
Seasonality Move:
14.88%
Sell
43
Comstock Resources (CRK)
is a Sell
Is Comstock Resources a Buy, Sell or Hold?
- The current Comstock Resources [CRK] share price is $15.57. The Score for CRK is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- CRK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CRK Stock Price Chart
What is Comstock Resources's stock price today?
-
The Comstock Resources share price today is $15.57
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRK is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $130.50
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.95 | Buy |
Relative Strength Index (14 RSI): | 75.58 | Buy |
Chaikin Money Flow: | 670774 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.84 - 14.58) | Buy |
Bollinger Bands (100): | (9.65 - 12.75) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.3 | Sell |
Relative Strength Index (14 RSI): | 64.59 | Buy |
Chaikin Money Flow: | 3149400 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (111.02 - 128.88) | Buy |
Bollinger Bands (100): | (119.18 - 142.3) | Sell |
CRK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.72 | Buy |
20-day SMA: | 13.54 | Buy |
50-day SMA: | 12.26 | Buy |
200-day SMA: | 10.47 | Buy |
8-day EMA: | 14.85 | Buy |
20-day EMA: | 13.86 | Buy |
50-day EMA: | 12.61 | Buy |
200-day EMA: | 11.08 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 112.07 | Buy |
20-day SMA: | 117.27 | Buy |
50-day SMA: | 121.92 | Buy |
200-day SMA: | 129.99 | Buy |
8-day EMA: | 116.28 | Buy |
20-day EMA: | 117.14 | Buy |
50-day EMA: | 121.91 | Buy |
200-day EMA: | 125.98 | Buy |
Comstock Resources Earnings Growth & CRK Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.88 per share, and an increase next year of $0.87 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.
Comstock Resources Technical Analysis
Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |